About » Office Locations » New England Division » New England News

Queens Resident Pleads Guilty to Ecstasy Trafficking Charge

MAR 30 (NEW HAVEN, Conn.) – Michael J. Ferguson Special Agent in Charge of the Drug Enforcement Administration for New England and Deirdre M. Daly, United States Attorney for the District of Connecticut, today announced that Phillip Stewart, 46, a citizen of Jamaica residing in Queens, N.Y., pleaded guilty yesterday in New Haven federal court to one count of conspiracy to distribute, and to possess with intent to distribute, MDA and MDMA.

MDA (Methylenedioxyamphetamine) is an analogue of MDMA (Methylenedioxymethamphetamine), and they are both commonly known as “ecstasy”.

According to court documents and statements made in court, Stewart conspired with Collin Fletcher and others to sell ecstasy to customers in Connecticut, New York and elsewhere.  On October 27, 2016, and again on November 1, 2016, investigators made two controlled purchases of ecstasy from Fletcher.  Stewart and Fletcher were arrested on November 18, 2016, after they attempted to sell approximately 10,000 capsules of ecstasy to an undercover officer.  The capsules had a combined weight of approximately 923 grams of MDA.

Stewart is scheduled to be sentenced by Chief U.S. District Judge Janet C. Hall on June 30, 2017, at which time he faces a maximum term of imprisonment of 20 years.  He is released on a $100,000 bond pending sentencing.  Fletcher, a citizen of Jamaica last residing in Bridgeport, pleaded guilty to the same charge on February 14, 2017, and awaits sentencing.  He has been detained since his arrest.

This matter is being investigated by the Drug Enforcement Administration’s New Haven Tactical Diversion Squad, which includes officers from the Bristol, Greenwich, Hamden, Milford, New Haven, Shelton, Vernon and Wilton Police Departments. 


Receive E-mail Updates Receive E-mail Updates @DEAHQ Twitter Account button Hover @DEAHQ Twitter Account button Report Synthetic Drug Source button Hover Report Synthetic Drug Source button

Stay Connected Facebook Twitter YouTube


A-Z Index  Accessibility   Contact Us  FOIA  Legal Policies & Disclaimers  
No FEAR Act   Privacy Policy Plug-Ins Whistleblower Protection